Apoptosis, Caspase Activation Inhibitor (AVEN) (C-Term) Peptide
AVEN
Reactivity: Human
BP
Sodium azide
-
- Target See all AVEN products
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Protein Region
- C-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
17 amino acids near the carboxy terminus of human Aven.
Human
-
-
- Application Notes
- Aven peptide is used for blocking activity of Aven.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- AVEN (Apoptosis, Caspase Activation Inhibitor (AVEN))
- Synonyms
- AVEN Peptide, pdcd12 Peptide, aven Peptide, wu:fc08c09 Peptide, si:ch211-150c22.4 Peptide, PDCD12 Peptide, 1700013A01Rik Peptide, 1700056A21Rik Peptide, mAven-L Peptide, mAven-S Peptide, apoptosis and caspase activation inhibitor Peptide, apoptosis, caspase activation inhibitor L homeolog Peptide, apoptosis, caspase activation inhibitor Peptide, Aven Peptide, AVEN Peptide, aven.L Peptide, aven Peptide
-
You are here:
